Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Not Yet Recruiting

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

NCT06982690

Conditions: Anesthesia, General, Anesthesia,Spinal, Bladder (Urothelial, Transitional Cell) Cancer, +22 more
Locations: Department of Urology, College of Medicine, National Taiwan University Taipei, Taiwan

View Trial Details

Not Yet Recruiting

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

NCT06976021

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +37 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy

NCT06973798

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerular Filtration Rate, +11 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery

NCT06960174

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NCT06957561

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

NCT06896552

Conditions: Adenocarcinoma, Cancer, Carcinoma, +25 more
Locations: Rabin Medical Center Petah Tikva, Israel

View Trial Details

Not Yet Recruiting

177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

NCT06880757

Conditions: Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

NCT06873672

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +46 more
Locations: Guizhou Medical University Guiyang, Guizhou, China

View Trial Details

Not Yet Recruiting

Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform

NCT06844513

Conditions: Adenocarcinoma, Carcinoma, Female Urogenital Diseases, +19 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Not Yet Recruiting

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

NCT06364904

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China

The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions